Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 04, 2022 Filed Jan 18, 2022 16:30 UTC |
COHEN MARC ADirector
|
GrantCommon Stock | 657 | $31.58 | $20,748.06 |
DisclosureSEC source: 0001209191-22-003503 · doc4.xml · nonDerivative · entry 1 COHEN MARC A · CIK 0001132945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,118 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 4, 2022. Read SEC document |
| January 04, 2022 Filed Jan 18, 2022 16:30 UTC |
COHEN ALAIN JDirector
|
GrantCommon Stock | 318 | $31.58 | $10,042.44 |
DisclosureSEC source: 0001209191-22-003501 · doc4.xml · nonDerivative · entry 1 COHEN ALAIN J · CIK 0001132946 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 4, 2022. Read SEC document |
| January 04, 2022 Filed Jan 18, 2022 16:30 UTC |
Salter MalcolmDirector
|
GrantCommon Stock | 428 | $31.58 | $13,516.24 |
DisclosureSEC source: 0001209191-22-003504 · doc4.xml · nonDerivative · entry 1 Salter Malcolm · CIK 0001825124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,380 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 4, 2022. Read SEC document |
| January 04, 2022 Filed Jan 18, 2022 16:30 UTC |
Dubin GlennDirector
|
GrantCommon Stock | 199 | $31.58 | $6,284.42 |
DisclosureSEC source: 0001209191-22-003502 · doc4.xml · nonDerivative · entry 1 Dubin Glenn · CIK 0001308597 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 4, 2022. Read SEC document |
| January 04, 2022 Filed Jan 18, 2022 21:30 UTC |
Anderson Kenneth CarlDirector
|
GrantCommon Stock | 278 | $31.58 | $8,779.24 |
DisclosureSEC source: 0001209191-22-003500 · doc4.xml · nonDerivative · entry 1 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,838 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 4, 2022. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 21:10 UTC |
Crystal AdamChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0001209191-21-071069 · doc4.xml · derivative · entry 2 Crystal Adam · CIK 0001825445 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,292 Underlying: Common Stock · 5,000 shares Expires 2029-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of this option vested and became exercisable on February 14, 2020, with the remainder vesting in 16 equal quarterly installments thereafter. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 21:10 UTC |
Crystal AdamChief Medical Officer
|
Exercise / conversionCommon Stock | 5,000 | $6.49 | $32,450.00 |
DisclosureSEC source: 0001209191-21-071069 · doc4.xml · nonDerivative · entry 1 Crystal Adam · CIK 0001825445 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2021 Filed Dec 17, 2021 16:28 UTC |
Salter MalcolmDirector
|
SaleCommon Stock | 755 | $30.25 | $22,838.75 |
DisclosureSEC source: 0001209191-21-070273 · doc4.xml · nonDerivative · entry 1 Salter Malcolm · CIK 0001825124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,952 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:30 UTC |
Fisher StewartChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 403 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001209191-21-069036 · doc4.xml · derivative · entry 6 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,994 Underlying: Common Stock · 403 shares Expires 2030-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option shall vest and become exercisable in 20 equal quarterly installments, with the first installment vesting on September 5, 2020. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:30 UTC |
Fisher StewartChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,786 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001209191-21-069036 · doc4.xml · derivative · entry 5 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,728 Underlying: Common Stock · 17,786 shares Expires 2028-04-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 20% of this option vested and became exercisable on May 1, 2019, with the remainder vesting in 16 equal quarterly installments thereafter. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:30 UTC |
Fisher StewartChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,373 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001209191-21-069036 · doc4.xml · derivative · entry 4 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,373 shares Expires 2026-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:30 UTC |
Fisher StewartChief Scientific Officer
|
Exercise / conversionCommon Stock | 403 | $4.98 | $2,006.94 |
DisclosureSEC source: 0001209191-21-069036 · doc4.xml · nonDerivative · entry 3 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:30 UTC |
Fisher StewartChief Scientific Officer
|
Exercise / conversionCommon Stock | 17,786 | $3.71 | $65,986.06 |
DisclosureSEC source: 0001209191-21-069036 · doc4.xml · nonDerivative · entry 2 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:30 UTC |
Fisher StewartChief Scientific Officer
|
Exercise / conversionCommon Stock | 2,373 | $2.11 | $5,007.03 |
DisclosureSEC source: 0001209191-21-069036 · doc4.xml · nonDerivative · entry 1 Fisher Stewart · CIK 0001824863 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2021 Filed Nov 19, 2021 16:30 UTC |
Salter MalcolmDirector
|
SaleCommon Stock | 755 | $40.11 | $30,283.05 |
DisclosureSEC source: 0001209191-21-065820 · doc4.xml · nonDerivative · entry 1 Salter Malcolm · CIK 0001825124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,707 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021. Read SEC document |
| October 15, 2021 Filed Oct 15, 2021 16:36 UTC |
Salter MalcolmDirector
|
SaleCommon Stock | 755 | $44.94 | $33,929.70 |
DisclosureSEC source: 0001209191-21-060568 · doc4.xml · nonDerivative · entry 1 Salter Malcolm · CIK 0001825124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,462 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021. Read SEC document |
| October 08, 2021 Filed Oct 12, 2021 20:30 UTC |
Crystal AdamChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0001209191-21-060230 · doc4.xml · derivative · entry 2 Crystal Adam · CIK 0001825445 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,292 Underlying: Common Stock · 10,000 shares Expires 2029-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of this option vested and became exercisable on February 14, 2020, with the remainder vesting in 16 equal quarterly installments thereafter. Read SEC document |
| October 08, 2021 Filed Oct 12, 2021 20:30 UTC |
Crystal AdamChief Medical Officer
|
Exercise / conversionCommon Stock | 10,000 | $6.49 | $64,900.00 |
DisclosureSEC source: 0001209191-21-060230 · doc4.xml · nonDerivative · entry 1 Crystal Adam · CIK 0001825445 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 16:54 UTC |
COHEN ALAIN JDirector
|
GrantCommon Stock | 222 | $44.99 | $9,987.78 |
DisclosureSEC source: 0001209191-21-059516 · doc4.xml · nonDerivative · entry 1 COHEN ALAIN J · CIK 0001132946 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021. F3 · balance_after: This amount has been adjusted to reflect 517 shares previously transferred from the Reporting Person to the Alain J. Cohen Revocable Trust. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 16:55 UTC |
COHEN MARC ADirector
|
GrantCommon Stock | 461 | $44.99 | $20,740.39 |
DisclosureSEC source: 0001209191-21-059522 · doc4.xml · nonDerivative · entry 1 COHEN MARC A · CIK 0001132945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021. F3 · balance_after: This amount has been adjusted to reflect 6,641 shares previously transferred from the Reporting Person to the Marc Andrew Cohen Revocable Trust. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 16:56 UTC |
Salter MalcolmDirector
|
GrantCommon Stock | 300 | $44.99 | $13,497.00 |
DisclosureSEC source: 0001209191-21-059530 · doc4.xml · nonDerivative · entry 1 Salter Malcolm · CIK 0001825124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,217 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 16:55 UTC |
Dubin GlennDirector
|
GrantCommon Stock | 138 | $44.99 | $6,208.62 |
DisclosureSEC source: 0001209191-21-059526 · doc4.xml · nonDerivative · entry 1 Dubin Glenn · CIK 0001308597 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 20:53 UTC |
Anderson Kenneth CarlDirector
|
GrantCommon Stock | 194 | $44.99 | $8,728.06 |
DisclosureSEC source: 0001209191-21-059515 · doc4.xml · nonDerivative · entry 1 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,560 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:53 UTC |
Crystal AdamChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001209191-21-059512 · doc4.xml · derivative · entry 5 Crystal Adam · CIK 0001825445 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,108 Underlying: Common Stock · 15,000 shares Expires 2030-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option shall vest and become exercisable in 20 equal quarterly installments, with the first installment vesting on September 5, 2020. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:53 UTC |
Crystal AdamChief Medical Officer
|
SaleCommon Stock | 5,112 | $45.99 | $235,118.77 |
DisclosureSEC source: 0001209191-21-059512 · doc4.xml · nonDerivative · entry 4 Crystal Adam · CIK 0001825445 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.89 to $46.30. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:53 UTC |
Crystal AdamChief Medical Officer
|
SaleCommon Stock | 8,176 | $45.32 | $370,563.30 |
DisclosureSEC source: 0001209191-21-059512 · doc4.xml · nonDerivative · entry 3 Crystal Adam · CIK 0001825445 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,112 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.85 to $45.845. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:53 UTC |
Crystal AdamChief Medical Officer
|
SaleCommon Stock | 1,712 | $44.25 | $75,756.34 |
DisclosureSEC source: 0001209191-21-059512 · doc4.xml · nonDerivative · entry 2 Crystal Adam · CIK 0001825445 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,288 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.57 to $44.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:53 UTC |
Crystal AdamChief Medical Officer
|
Exercise / conversionCommon Stock | 15,000 | $4.98 | $74,700.00 |
DisclosureSEC source: 0001209191-21-059512 · doc4.xml · nonDerivative · entry 1 Crystal Adam · CIK 0001825445 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 22:33 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 1,311 | $50.04 | $65,604.01 |
DisclosureSEC source: 0001209191-21-058111 · doc4.xml · nonDerivative · entry 2 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ERP Business Holdings, LP Disclosed balance after: 503,126 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F5 · ownership.nature: Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein. Read SEC document |
| September 27, 2021 Filed Sep 29, 2021 22:33 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 539 | $50.04 | $26,969.03 |
DisclosureSEC source: 0001209191-21-058111 · doc4.xml · nonDerivative · entry 1 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 31,681 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 24, 2021 Filed Sep 24, 2021 20:51 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 2,115 | $50.10 | $105,963.62 |
DisclosureSEC source: 0001209191-21-057633 · doc4.xml · nonDerivative · entry 8 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ERP Business Holdings, LP Disclosed balance after: 504,437 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F5 · ownership.nature: Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein. Read SEC document |
| September 24, 2021 Filed Sep 24, 2021 20:51 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 900 | $50.11 | $45,101.25 |
DisclosureSEC source: 0001209191-21-057633 · doc4.xml · nonDerivative · entry 7 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 32,220 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 23, 2021 Filed Sep 24, 2021 20:51 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 1,007 | $51.08 | $51,434.74 |
DisclosureSEC source: 0001209191-21-057633 · doc4.xml · nonDerivative · entry 6 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ERP Business Holdings, LP Disclosed balance after: 506,552 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.00 to $51.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F5 · ownership.nature: Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein. Read SEC document |
| September 23, 2021 Filed Sep 24, 2021 20:51 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 11,801 | $50.35 | $594,193.33 |
DisclosureSEC source: 0001209191-21-057633 · doc4.xml · nonDerivative · entry 5 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ERP Business Holdings, LP Disclosed balance after: 507,559 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.99. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F5 · ownership.nature: Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein. Read SEC document |
| September 23, 2021 Filed Sep 24, 2021 20:51 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 446 | $51.09 | $22,784.40 |
DisclosureSEC source: 0001209191-21-057633 · doc4.xml · nonDerivative · entry 4 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 33,120 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.04 to $51.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 23, 2021 Filed Sep 24, 2021 20:51 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 5,926 | $50.35 | $298,359.29 |
DisclosureSEC source: 0001209191-21-057633 · doc4.xml · nonDerivative · entry 3 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 33,566 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.99. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 20:51 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 7,004 | $50.09 | $350,860.48 |
DisclosureSEC source: 0001209191-21-057633 · doc4.xml · nonDerivative · entry 2 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ERP Business Holdings, LP Disclosed balance after: 519,360 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F5 · ownership.nature: Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 20:51 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 3,544 | $50.10 | $177,554.40 |
DisclosureSEC source: 0001209191-21-057633 · doc4.xml · nonDerivative · entry 1 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 39,492 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.31. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 21, 2021 Filed Sep 21, 2021 23:26 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 5,333 | $50.14 | $267,409.95 |
DisclosureSEC source: 0001209191-21-057118 · doc4.xml · nonDerivative · entry 4 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ERP Business Holdings, LP Disclosed balance after: 526,364 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F4 · ownership.nature: Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein. Read SEC document |
| September 21, 2021 Filed Sep 21, 2021 23:26 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 4,988 | $50.13 | $250,051.43 |
DisclosureSEC source: 0001209191-21-057118 · doc4.xml · nonDerivative · entry 3 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 43,036 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 19:25 UTC |
Salter MalcolmDirector
|
SaleCommon Stock | 755 | $49.89 | $37,666.95 |
DisclosureSEC source: 0001209191-21-057117 · doc4.xml · nonDerivative · entry 1 Salter Malcolm · CIK 0001825124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,917 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 23:26 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 5,688 | $50.05 | $284,686.68 |
DisclosureSEC source: 0001209191-21-057118 · doc4.xml · nonDerivative · entry 2 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ERP Business Holdings, LP Disclosed balance after: 531,697 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F4 · ownership.nature: Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 23:26 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 5,152 | $50.04 | $257,808.14 |
DisclosureSEC source: 0001209191-21-057118 · doc4.xml · nonDerivative · entry 1 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 48,024 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 16, 2021 Filed Sep 16, 2021 23:31 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 346 | $50.01 | $17,305.05 |
DisclosureSEC source: 0001209191-21-056482 · doc4.xml · nonDerivative · entry 7 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ERP Business Holdings, LP Disclosed balance after: 510,385 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.045. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F4 · ownership.nature: Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein. Read SEC document |
| September 16, 2021 Filed Sep 16, 2021 23:31 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 25,807 | $48.62 | $1,254,676.98 |
DisclosureSEC source: 0001209191-21-056482 · doc4.xml · nonDerivative · entry 6 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ERP Business Holdings, LP Disclosed balance after: 510,731 F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.50 to $49.165. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F4 · ownership.nature: Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein. Read SEC document |
| September 16, 2021 Filed Sep 16, 2021 23:31 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 346 | $50.01 | $17,302.94 |
DisclosureSEC source: 0001209191-21-056482 · doc4.xml · nonDerivative · entry 5 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 53,176 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 23:31 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 24,193 | $48.97 | $1,184,690.08 |
DisclosureSEC source: 0001209191-21-056482 · doc4.xml · nonDerivative · entry 4 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ERP Business Holdings, LP Disclosed balance after: 563,538 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.80 to $49.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F4 · ownership.nature: Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 23:31 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 30,000 | $48.71 | $1,461,204.00 |
DisclosureSEC source: 0001209191-21-056482 · doc4.xml · nonDerivative · entry 3 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 53,522 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.25 to $49.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 23:31 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 492 | $50.03 | $24,613.58 |
DisclosureSEC source: 0001209191-21-056482 · doc4.xml · nonDerivative · entry 2 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ERP Business Holdings, LP Disclosed balance after: 587,731 F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.145. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. F4 · ownership.nature: Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 23:31 UTC |
Prokupets ElenaDirector
|
SaleCommon Stock | 492 | $50.01 | $24,603.39 |
DisclosureSEC source: 0001209191-21-056482 · doc4.xml · nonDerivative · entry 1 Prokupets Elena · CIK 0001824823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 83,522 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.145. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.